Book Value per Share: Ascentage Pharma Group (AAPG)
Ascentage Pharma Group (AAPG) dominates the pricing of onco-hematological agents thanks to its unique inhibitors, while supply reliability is ensured by costly thermoregulation systems. This chart shows the asset value is currently at 0.88. The business is increasing sales of its key product in China, although significant expenditures on the development of new drugs are temporarily limiting free cash flow.
Summary analytical data breakdowns for ascentage.com (AAPG)
Book value per share is utilized during screening to assess the issuer's financial stability. This metric is calculated as the ratio of net assets to the number of outstanding shares, determining the actual value of the owner's stake. For Ascentage Pharma Group (AAPG), this indicator reflects the ability to fund the development of targeted anti-tumor drugs without external loans. The price action on the equity per ordinary share chart demonstrates the capital's dependence on the success of clinical trials.